Harmaline inhibits the (Na+ + K+)-dependent ATPase by affecting both Na+ and K+ activation.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000255:Adenosine Triphosphate / Q000378:metabolism; D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000648:ultrastructure; D004789:Enzyme Activation / Q000187:drug effects; D006246:Harmaline / Q000494:pharmacology*; D066298:In Vitro Techniques; D007700:Kinetics; D008861:Microsomes / Q000201:enzymology; D011188:Potassium / Q000494:pharmacology*; D051381:Rats; D012964:Sodium / Q000494:pharmacology*
D000470:Alkaloids; D000255:Adenosine Triphosphate; D012964:Sodium; D006246:Harmaline; D000251:Adenosine Triphosphatases; D011188:Potassium